Overview
- RoundTable bought the practitioner-trusted skincare and sun protection brand from a shareholder group led by 1315 Capital, and terms were not disclosed.
- The transaction is a platform investment from RoundTable’s $800 million Equity Fund VI with senior debt arranged by Capital One alongside CIBC Bank USA and Lord Abbett.
- RoundTable plans to accelerate brand awareness, broaden channel penetration, and add new products while maintaining Colorescience’s science-first positioning.
- Colorescience is known for mineral-based, clinically validated formulas and sells through professional practices, direct-to-consumer, and leading e-commerce platforms.
- Industry reports cite annual sales approaching $100 million, and the brand’s roots span more than two decades with prior ownership ties to SkinMedica and Allergan.